[Event Report] WHO Regional Committee for the Western Pacific Related Event: “AMR: A Global Health Crisis” (September 25, 2021)
date : 4/13/2022
Tags: AMR
*A video of the Symposium has been published on April 13, 2022.
*A report on the Symposium has been published on April 2, 2022.
AMR Alliance Japan (Secretariat: Health and Global Policy Institute) hosted a WHO Regional Committee for the Western Pacific Related Event: “AMR: A Global Health Crisis”
Antimicrobial resistance (AMR) occurs when the microorganisms that cause infectious disease grow resistant over time to the antimicrobials used to treat them. If not enough is done to combat this problem, it is estimated that AMR will cause more deaths than cancer by 2050. Urgent action is needed.
In celebration of the 72nd session of the WHO Regional Committee for the Western Pacific to be held in Himeji in October, this symposium shared the current state of AMR-related issues within Japan and overseas, and discussed future countermeasures.
You can watch the day’s proceedings below.
[Overview]
■Date and Time: Saturday, September 25, 2021, from 16:00-18:00 JST
■Language: Japanese and English (Simultaneous Interpretation will be available)
■Venue:
– Online Participation (Zoom Webinar)
– Himeji Venue
■Participation fee: Free
■Organizers: AMR Alliance Japan, Himeji City, Himeji Medical Association, Himeji Dental Association
■Supported by: Ministry of Health, Labour and Welfare (TBD), Himeji Pharmacist Association, Hyogo Nursing Association Seiban Branch
■Sponsor: Japan Pharmaceutical Manufacturers Association
[Program] (Titles Omitted)
15:50-15:55 Greetings (For Himeji Venue Only)
Etsuji Ishibashi (Chairman, Himeji Medical Association)
16:00-16:05 Opening Remarks and Introduction
Ryoji Noritake (CEO, Boad Member, Health and Global Policy Institute)
16:05-16:25 Message
Takeshi Kasai (Regional Director for the Western Pacific, World Health Organization (WHO) )
Yasuhisa Shiozaki (Member of the House of Representatives; Former Minister of Health, Labour and Welfare; Member, Global Leaders Group on Antimicrobial Resistance; Chairman, Special Mission Committee on Data Health Advancement, Liberal Democratic Party of Japan(LDP))
Shigeru Omi (President, Japan Community Health care Organization (JCHO); Chairperson, Committee for the Promotion of Pandemic Influenza and New Infectious Disease Preparedness and Response)
16:25-16:40 Lecture 1 “AMR as a Global Health Crisis: A message from the United Kingdom”
Dame Sally Davies (UK Special Envoy on Antimicrobial Resistance)
16:40-16:55 Lecture 2 “AMR in Japan and Expectations toward Future”
Norio Ohmagari (Disease Control and Prevention Center, National Center for Global Health and Medicine (NCGM); Director, AMR Clinical Reference Center, NCGM)
16:55-17:55 Panel Discussion: Antimicrobial Stewardship
Panelists:
Socorro Escalante (Regional Coordinator for the programme on Essential Medicines and Health Technologies (EMT) and antimicrobial resistance (AMR), Western Pacific Regional Office, WHO)
Norio Ohmagari (Disease Control and Prevention Center, National Center for Global Health and Medicine (NCGM); Director, AMR Clinical Reference Center, NCGM)
Testuji Kawamura (Director, NHO Himeji Medical Center)
Kyoko Ama (Representative, Children and Healthcare Project; Fellow, Health and Global Policy Institute)
Takeshi Enami (Director, Tuberculosis and Infectious Diseases Control Division, Health Service Bureau, Ministry of Health, Labour and Welfare)
Hajime Inoue (Assistant Minister for Global Health and Welfare, Ministry of Health, Labour and Welfare)
Tetsuya Ito (Chair, International Affairs Committee, Japan Pharmaceutical Manufacturers Association)
Moderator:
Ryoji Noritake (CEO, Boad Member, Health and Global Policy Institute)
17:55 -18:00 Closing Remarks
Hideyasu Kiyomoto (Mayor of Himeji City)
Top Research & Recommendations Posts
- [Policy Recommendations] Joint Statement “Protecting the Health of Both the Planet and People — A Japan-Model Planetary Health Strategy to Turn the Climate Crisis into an Opportunity for Health, the Economy, and Growth” (June 24, 2026)
- [Policy Recommendations] Toward Further Advancement of Measures Against Antimicrobial Resistance (AMR) (July 15, 2026)
- [Announcement] HGPI Joins the UHC2030 Task Force for the 2027 UN High-Level Meeting on UHC (July 6, 2026)
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Research Report] AMR Policy Update #6: The New Global Action Plan on AMR (Part 1)
- [Research Report] AMR Policy Update #7: The New Global Action Plan on AMR (Part 2)
- [Policy Recommendations] Hearing Loss Project “Recommendations on Coherent Countermeasures for Hearing Loss Throughout the Life Course: Building a Society Where Everyone Can Access Appropriate Hearing Care” (July 30, 2026)
- [Research Report] AMR Policy Update #9: Stockholm Residents’ Awareness and Practices in Returning and Recycling Pharmaceuticals: Findings from Local Interviews (July 15, 2026)
- [Policy Recommendations] Expectations for a System that Spans Diseases, Ministries, and Agencies for the Effective Promotion of Patient and Public Involvement (PPI) in Research and Development (June 30, 2026)
- [Activity Report] HGPI Contributed to the Development of the Civil 7 (C7) Global Health Working Group’s Climate and Health Thematic Brief for the G7 (June 25, 2026)
Featured Posts
-
2026-06-19
[Recommendations] Strengthening Epidemiology Education in the Veterinary Field for the One Health Era (June 19, 2026)
-
2026-07-21
[Announcement] Announcement of the 2nd Kiyoshi Kurokawa Award Recipient
-
2026-07-22
[Registration Open] Second Session of the Planetary Health Academy (Starts September 2026)
-
2026-07-31
[Policy recommendation] Reliable Policy Implementation for Early Detection and Early Intervention of Chronic Kidney Disease (CKD) (July 31, 2026)
-
2026-08-05
[Registration Open] (Webinar) The 4th J-PEP Seminar “The History of PPI in Japan and My Own PPI Journey” (September 30, 2026)



